Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SYNJARDY DIN 02456613

Status: Marketed
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: EMPAGLIFLOZIN
Available to quote

Health Canada record

Active ingredient(s)EMPAGLIFLOZIN 12.5 MG; METFORMIN HYDROCHLORIDE 850 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA10BD20 METFORMIN AND EMPAGLIFLOZIN
Original market date03-Aug-2016
Current status date03-Aug-2016
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing EMPAGLIFLOZIN

DINProductCompanyFormStrengthStatus
02443937JARDIANCEBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 10 MGMarketed
02443945JARDIANCEBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 25 MGMarketed
02456575SYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 500 MGMarketed
02456583SYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 850 MGMarketed
02456591SYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 1000 MGMarketed
02456621SYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 12.5 MG; METFORMIN HYDROCHLORIDE 1000 MGMarketed
02459752GLYXAMBIBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 10 MG; LINAGLIPTIN 5 MGCancelled Post Market
02459760GLYXAMBIBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletEMPAGLIFLOZIN 25 MG; LINAGLIPTIN 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
183112016-07-29New Drug Submission (NDS)

International API supply for EMPAGLIFLOZIN

59 active FDA Drug Master Files.

Request a quote for SYNJARDY

How to read a Canadian DIN record